0000899243-21-008619.txt : 20210301 0000899243-21-008619.hdr.sgml : 20210301 20210301161523 ACCESSION NUMBER: 0000899243-21-008619 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210226 FILED AS OF DATE: 20210301 DATE AS OF CHANGE: 20210301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaudhary Kleem CENTRAL INDEX KEY: 0001817587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39425 FILM NUMBER: 21697915 MAIL ADDRESS: STREET 1: C/O CHECKMATE PHARMACEUTICALS, INC. STREET 2: 245 MAIN STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001651431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 364813934 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 978-503-2124 MAIL ADDRESS: STREET 1: 245 MAIN STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-26 0 0001651431 Checkmate Pharmaceuticals, Inc. CMPI 0001817587 Chaudhary Kleem C/O CHECKMATE PHARMACEUTICALS, INC. 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Business Officer Common Stock 2021-02-26 4 M 0 2000 2.62 A 8000 D Stock Option (right to buy) 2.62 2021-02-26 4 M 0 2000 0.00 D 2029-11-13 Common Stock 2000 97508 D 25% of the shares subject to such option vested and became exercisable on November 1, 2020 with the remainder to vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Kleem Chaudhary 2021-03-01